Search results for "malattie"

showing 10 items of 1963 documents

Back pain after photodynamic therapy with verteporfin.

2005

Purpose To report the incidence of back pain after photodynamic therapy, which suggests methods for prevention that are related to its pathogenesis. Design Retrospective case series. Methods We retrospectively observed 548 patients who had undergone photodynamic therapy with verteporfin. Results Of 548 patients at the first treatment, 14 patients (2.6%) experienced pain during the infusion. Eleven patients were being treated for age-related macular degeneration; their mean age was 81 years, which significantly differed from the mean age of the overall age-related macular degeneration group ( P = .003). The pain was mild in eight patients, moderate in four patients, and severe in two patient…

Malemedicine.medical_specialtyPorphyrinsmedicine.medical_treatmentPhotodynamic therapyMacular Degenerationback painphotodynamic therapymedicineBack painHumansInfusions IntravenousAgedRetrospective StudiesAged 80 and overPhotosensitizing AgentsMild painSettore MED/30 - Malattie Apparato Visivobusiness.industryIncidence (epidemiology)IncidenceVerteporfinRetrospective cohort studyMacular degenerationMiddle Agedmedicine.diseaseVerteporfinLow back painChoroidal NeovascularizationSurgeryOphthalmologyPhotochemotherapyBack PainMyopia DegenerativeFemalemedicine.symptombusinessmedicine.drugAmerican journal of ophthalmology
researchProduct

A strange pneumonia

2013

We report the case of a 62-year-old man with non-ST elevation myocardial infarction complicated by partial rupture of the antero-lateral papillary muscle in which severe mitral regurgitation with lateralized direction towards the right pulmonary veins gave unilateral pulmonary oedema, resembling an acute pneumonia.Unilateral pulmonary oedema is a rare entity, more frequently appearing as opacity of the right lung and always associated with severe mitral regurgitation. It is very important to suspect and promptly recognize unilateral pulmonary oedema because initial misdiagnosis leads to a delay in the initiation of appropriate treatment and to an increased risk of mortality.

Malemedicine.medical_specialtyPulmonary Edema030204 cardiovascular system & hematologyPulmonary oedemaDiagnosis Differential03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumanspneumoniaMyocardial infarctionNon-ST Elevated Myocardial InfarctionPapillary muscleMitral regurgitationLungbusiness.industryRare entityGeneral MedicineMiddle Agedmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareMyocardial infarctionPneumoniamedicine.anatomical_structureIncreased risk030228 respiratory systemCardiologyCardiology and Cardiovascular MedicinebusinessJournal of Cardiovascular Medicine
researchProduct

Use of direct oral anticoagulants in very elderly patients: a case report of apixaban in an ultracentenary patient.

2019

no

Malemedicine.medical_specialtyPyridonesFrail ElderlyTreatment outcomeMEDLINEAdministration Oralanticoagulants elderlyAtrial FibrillationmedicineHumansFrail elderlyIntensive care medicineGeriatric AssessmentAged 80 and overbusiness.industryGeriatric assessmentGeneral MedicineSettore MED/11 - Malattie Dell'Apparato CardiovascolareChronic diseaseTreatment OutcomeChronic DiseasePyrazolesApixabanCardiology and Cardiovascular Medicinebusinessmedicine.drugFactor Xa InhibitorsJournal of cardiovascular medicine (Hagerstown, Md.)
researchProduct

Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: A randomized trial

2009

BACKGROUND: Low-dose oral vitamin K decreases the international normalized ratio (INR) in overanticoagulated patients who receive warfarin therapy. Its effects on bleeding events are uncertain. OBJECTIVE: To see whether low-dose oral vitamin K reduces bleeding events over 90 days in patients with warfarin-associated coagulopathy. DESIGN: Multicenter, randomized, placebo-controlled trial. Randomization was computer-generated, and participants were allocated to trial groups by using sequentially numbered study drug containers. Patients, caregivers, and those who assessed outcomes were blinded to treatment assignment. SETTING: 14 anticoagulant therapy clinics in Canada, the United States, and …

Malemedicine.medical_specialtyRandomizationVitamin Kmedicine.drug_classAdministration OralHemorrhageoral vitamin k anticoagulantsPlacebolaw.inventionSettore MED/15 - Malattie Del SanguePlacebosRandomized controlled trialOral administrationlawInternal medicineThromboembolismInternal MedicinemedicineOutpatient clinicHumansInternational Normalized RatioAgedAged 80 and overbusiness.industryAnticoagulantWarfarinAge FactorsAnticoagulantsGeneral MedicineMiddle AgedAntifibrinolytic AgentsSurgeryClinical trialTreatment OutcomeFemaleWarfarinbusinessmedicine.drug
researchProduct

The incidence of hip, forearm, humeral, ankle, and vertebral fragility fractures in Italy: results from a 3-year multicenter study

2010

Introduction: We aimed to assess the incidence and hospitalization rate of hip and "minor" fragility fractures in the Italian population.Methods: We carried out a 3-year survey at 10 major Italian emergency departments to evaluate the hospitalization rate of hip, forearm, humeral, ankle, and vertebral fragility fractures in people 45 years or older between 2004 and 2006, both men and women. These data were compared with those recorded in the national hospitalizations database (SDO) to assess the overall incidence of fragility fractures occurring at hip and other sites, including also those events not resulting in hospital admissions.Results: We observed 29,017 fractures across 3 years, with…

Malemedicine.medical_specialtySettore MED/06 - Oncologia MedicaOsteoporosisImmunologyWristFractures BoneForearmCost of IllnessRheumatologymedicineSettore MED/33 - Malattie Apparato LocomotoreHumansImmunology and AllergyHumerusStatistics & numerical dataBoneAgedbusiness.industryhip fractures vertebral fracturesIncidence (epidemiology)Settore MED/34 - Medicina Fisica E RiabilitativaIncidenceAged; Cost of Illness; Female; Forearm Injuries; epidemiology/etiology; Fractures; Bone; Hip Injuries; Hospitalization; statistics /&/ numerical data; Humans; Humerus; injuries; Incidence; Italy; epidemiology; Male; Middle Aged; Osteoporosis; complications; Spinal Fracturesfragility fractures; osteoporosisfragility fracturesForearm InjuriesHumerusMiddle Agedmedicine.diseaseMale; Middle Aged; Hip Injuries; Humerus; Spinal Fractures; Cost of Illness; Female; Forearm Injuries; Italy; Hospitalization; Humans; Osteoporosis; Fractures Bone; Aged; IncidenceSurgeryHospitalizationmedicine.anatomical_structureItalyOrthopedic surgeryPhysical therapyOsteoporosisSpinal FracturesFemaleAnklebusinessFracturesHip InjuriesResearch ArticleArthritis Research & Therapy
researchProduct

The predictive role of C-reactive protein in patients with hypertension and subclinical atherosclerosis.

2009

Recent guidelines published by the joint European Society of Hypertension/European Society of Cardiology have suggested the inclusion of C-reactive protein (CRP) in the standard assessment of cardiovascular risk in hypertensive patients, but little data is available on the role of CRP in patients with carotid lesions. We studied in 472 subjects, 236 with and 236 without hypertension, gender- and age-matched, with and without early stages of atherosclerosis (e.g. those with asymptomatic intima-media thickness >0.9 mm), the influence of all the other traditional cardiovascular risk factors (e.g. older age, male gender, obesity, diabetes, smoking habit, family history of coronary artery diseas…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaInflammationAsymptomaticCoronary artery diseasePredictive Value of TestsRisk FactorsInternal medicineDiabetes mellitusCRP Hypertension Subclinical Atherosclerosis atherosclerosisInternal MedicinemedicineHumansIn patientFamily historyAgedbiologybusiness.industryC-reactive proteinMiddle Agedmedicine.diseaseC-reactive protein hypertension inflammation event atherosclerosisAtherosclerosisObesitySettore MED/11 - Malattie Dell'Apparato CardiovascolareCerebrovascular DisordersC-Reactive ProteinCase-Control StudiesHypertensionCardiologybiology.proteinFemalemedicine.symptombusinessBiomarkersFollow-Up StudiesInternal medicine journal
researchProduct

The relationships between lipid ratios and arterial stiffness

2017

Although dyslipidemia is associated with cardiovascular disease, there are conflicting data about the role of serum lipids and their ratios in promoting arterial stiffness. The authors aimed to compare serum lipid profiles to predict arterial stiffness, which was assessed by brachial‐ankle pulse wave velocity in young Chinese men. A total of 1015 participants aged 18 to 44 years without serious comorbidities were recruited for conventional detection. Anthropometrics, brachial‐ankle pulse wave velocity, serum lipids, and other laboratory data were measured. Univariate analysis and multivariate logistic regression were performed to examine the relationship between serum lipid profiles and bra…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaLipoproteinsEndocrinology Diabetes and Metabolism030204 cardiovascular system & hematology03 medical and health sciencesVascular Stiffness0302 clinical medicineInternal medicineInternal MedicineHumansMedicine030212 general & internal medicineARTERIOSCLEROSIS - ARTERIAL STIFFNESS - LIPIDS - HYPERTENSIONSettore MED/14 - Nefrologiabusiness.industrynutritional and metabolic diseasesmedicine.diseaseLipidsSettore MED/11 - Malattie Dell'Apparato CardiovascolareSurgeryHypertensionArterial stiffnessCardiologyArterial Stiffnesslipids (amino acids peptides and proteins)Cardiology and Cardiovascular Medicinebusiness
researchProduct

Hemorheological parameters in Monoclonal Gammopathy of Undetermined Significance (MGUS).

2018

There is scarcity of information about the hemorheological pattern in subjects with Monoclonal Gammopathy of Undetermined Significance (MGUS). This preliminary research is focused on the behaviour of whole-blood and plasma viscosity, haematocrit and erythrocyte deformability in the above clinical condition. We enrolled 21 MGUS subjects (10 women and 11 men; mean age 66.4 ± 11.6 years). In fasting venous blood we examined whole-blood and plasma viscosity at high and low shear rates, haematocrit, the ratios between whole-blood viscosity (at high and low shear rate) and haematocrit × 100, the ratio between plasma viscosity at low and high shear rate, and the erythrocyte deformability expressed…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaPhysiologyBlood viscosity030204 cardiovascular system & hematologyMonoclonal Gammopathy of Undetermined SignificanceSettore MED/15 - Malattie Del Sangue03 medical and health sciencesViscosity0302 clinical medicinehemic and lymphatic diseasesPhysiology (medical)Internal medicineErythrocyte DeformabilitymedicineErythrocyte deformabilityHumanscardiovascular diseasesPlasma viscosityParaproteinemia; blood viscosity; erythrocyte deformability; plasma viscosityAgedChemistryMean ageHematologyVenous bloodmedicine.diseaseBlood ViscosityShear rateParaproteinemiaEndocrinology030220 oncology & carcinogenesisplasma viscosityFemaleCardiology and Cardiovascular MedicineRheologyMonoclonal gammopathy of undetermined significanceClinical hemorheology and microcirculation
researchProduct

Inappropriately high left ventricular mass: Marker of very high cardiovascular risk in patients with chronic kidney disease

2012

There is increasing knowledge of the burden of cardiovascular (CV) diseases affecting patients with chronic kidney disease (CKD). CV diseases are the main cause of death in the CKD population, and the majority of patients with CKD die before ever reaching the end-stage renal disease; in fact, for patients with CKD, the risk of a fatal CV event is much higher than the risk to develop end-stage renal disease. Although patients with CKD manifest a high prevalence of traditional CV risk factors, this does not fully account for the burden of CV diseases in CKD.

Malemedicine.medical_specialtySettore MED/09 - Medicina Internabusiness.industryPhysiologymedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareLeft ventricular massEndocrinologyCardiovascular DiseasesInternal medicineCardiovascular DiseasemedicineCardiologyInternal MedicineHumansKidney Failure ChronicIn patientFemaleHypertrophy Left VentricularbusinessCardiology and Cardiovascular MedicineUltrasonographyKidney diseaseHuman
researchProduct

Human Hypertension Is Characterized by a Lack of Activation of the Antihypertensive Cardiac Hormones ANP and BNP

2012

ObjectivesThis study sought to investigate plasma levels of circulating cardiac natriuretic peptides, atrial natriuretic peptide (ANP) and B-type or brain natriuretic peptide (BNP), in the general community, focusing on their relative differences in worsening human hypertension.BackgroundAlthough ANP and BNP are well-characterized regulators of blood pressure in humans, little is known at the population level about their relationship with hypertension. The authors hypothesized that hypertension is associated with a lack of activation of these hormones or their molecular precursors.MethodsThe study cohort (N = 2,082, age >45 years) was derived from a random sample from Rochester, Minnesota, …

Malemedicine.medical_specialtySettore MED/09 - Medicina Internahypertensionmedicine.drug_class030204 cardiovascular system & hematologyCardiac hormonesArticle03 medical and health sciences0302 clinical medicineAtrial natriuretic peptideInternal medicineNatriuretic Peptide BrainmedicineNatriuretic peptideHumanscardiovascular diseasesBNP; ANP; Human HypertensionAged030304 developmental biology0303 health sciencesnatriuretic peptideExtramuralbusiness.industryPlasma levelsMiddle AgedBrain natriuretic peptideSettore MED/11 - Malattie Dell'Apparato CardiovascolareproBNPEndocrinologyNT-proBNPHuman HypertensionLinear Modelscardiovascular systemFemaleCardiology and Cardiovascular MedicinebusinessAtrial Natriuretic Factorhormones hormone substitutes and hormone antagonistsANPcirculatory and respiratory physiologyBNPJournal of the American College of Cardiology
researchProduct